IFNG and asthma: The most noticeable finding was the changes in serum IFN-γ concentrations: a significant increase in this cytokine following the administration of PCV13 was primarily observed in patients with T2-high asthma and in those who had fewer asthma exacerbations compared to the pre-vaccination period.